GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Enlivex Therapeutics ENLV · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.37

+7.87%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Enlivex Therapeutics

Our reporting

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -4.48 a share.

Past results

Reported against what analysts expected

25 Sept 202618 Sept 202611 Sept 20264 Sept 202626 Jun 202619 Jun 2026
Earnings per share-4.96-1.20-1.20-0.31-0.15-0.15
Forecast-4.96-0.31-0.31-0.31-0.02-0.02

Key events

  1. 27 Oct 202616-to-1 reverse split
  2. 9 Jul 202615-to-1 reverse split
  3. 26 Mar 20191-to-1 reverse split
  4. 6 Mar 20198-to-1 reverse split
  5. 25 Sept 20175-to-1 reverse split
  6. 30 Jul 2014Listed

Enlivex Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.